Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS
Version 2 2024-06-04, 08:30
Version 1 2021-10-21, 09:41
journal contribution
posted on 2024-06-04, 08:30 authored by MF Azari, C Profyris, Michael Le GrandeMichael Le Grande, EC Lopes, J Hirst, S Petratos, SS CheemaEffects of intraperitoneal injection of Rofecoxib in a mouse model of ALS
History
Journal
European Journal of NeurologyVolume
12Pagination
357-364Location
EnglandPublisher DOI
ISSN
1351-5101eISSN
1468-1331Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalIssue
5Publisher
WILEYUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesNeurosciences & Neurologyamyotrophic lateral sclerosiscyclooxygenase 2microglianeuroinflammationprostaglandin E2RofecoxibSOD1-G93Asoluble tumour necrosis factor receptor 1AMYOTROPHIC-LATERAL-SCLEROSISPROTECTS MOTOR-NEURONSFAMILIAL ALSCYCLOOXYGENASE-2EXPRESSIONRATDEATHMICEINHIBITIONACTIVATION
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC